CNAO National Center of Oncological Hadrontherapy clinical trials
CNAO National Center of Oncological Hadrontherapy is the lead sponsor of 6 current clinical trials in our Italy register. 6 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Head and Neck Cancer.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by CNAO National Center of Oncological Hadrontherapy
6 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma
NCT05733910 · ClinicalTrials.gov ↗ · Carcinoma, Adenoid Cystic, Head and Neck Cancer
|
Not applicable | Recruiting | 2023-11 | Italy |
|
Innovative SolutIons for DosimEtry in Hadrontherapy (INSIDE)
NCT03662373 · ClinicalTrials.gov ↗ · Particle Therapy
|
Observational | Recruiting | 2019-07 | Italy |
|
Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract
NCT05478876 · ClinicalTrials.gov ↗ · Malignant Melanoma, Gynecologic Cancer
|
Not applicable | Recruiting | 2020-09 | Italy |
|
Longitudinal Registry Including Patients Treated With Heavy Particles
NCT05203250 · ClinicalTrials.gov ↗ · Cancer, Oncology, Radiation Exposure
|
Observational | Recruiting | 2021-06 | Italy |
|
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
NCT05947149 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Skull Base--Cancer, Brain Cancer
|
Observational | Recruiting | 2023-03 | Italy |
|
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
NCT05457595 · ClinicalTrials.gov ↗ · Tumor Recurrence, Malignant Epithelial Neoplasm of Vulva, Malignant Epithelial Tumor of Ovary
|
Not applicable | Recruiting | 2021-02 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in CNAO National Center of Oncological Hadrontherapy trials
15 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 6 | 6 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Head and Neck Cancer
Sponsors with the most current trials registered for this condition.
Questions about CNAO National Center of Oncological Hadrontherapy trials
How many clinical trials does CNAO National Center of Oncological Hadrontherapy sponsor?
CNAO National Center of Oncological Hadrontherapy is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.
Are CNAO National Center of Oncological Hadrontherapy trials recruiting?
Yes. 6 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.